Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Clinical trial NCT06562777 · RECRUITING

Trial details

NCT number: NCT06562777
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Start date: 2023-09-15
Primary completion: 2026-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.